AKT1 and neuroblastoma: Collectively, this study suggests that S(+)-ibuprofen can reduce the malignancy of unfavorable neuroblastoma cells by modulating the expression of MYC, MYCN, AKT, p53 and by changing the gene expression profile towards a less aggressive phenotype.